Jubilant Pharmova Limited (NSE:JUBLPHARMA) — Market Cap & Net Worth

$1.68 Billion USD · Rs155.22 Billion INR · Rank #6927

Market Cap & Net Worth: Jubilant Pharmova Limited (JUBLPHARMA)

Jubilant Pharmova Limited (NSE:JUBLPHARMA) has a market capitalization of $1.68 Billion (Rs155.22 Billion) as of June 17, 2026. Listed on the NSE stock exchange, this India-based company holds position #6927 globally and #312 in its home market, demonstrating a 2.37% increase in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Jubilant Pharmova Limited's stock price Rs980.00 by its total outstanding shares 158387168 (158.39 Million). Review how much debt does Jubilant Pharmova Limited carry to assess the company's total debt and financial obligations.

Jubilant Pharmova Limited Market Cap History: 2015 to 2026

Jubilant Pharmova Limited's market capitalization history from 2015 to 2026. Data shows growth from $564.68 Million to $1.68 Billion (11.32% CAGR).

Index Memberships

Jubilant Pharmova Limited is a constituent of 5 market indices:

Index	Total Market Cap	Weight (%)	Rank by Market Cap
NIFTY 500 NIFTY500	$3.11 Trillion	0.05%	#271 of 500
NIFTY ALHPA 50 NIFTYALI	$345.91 Billion	0.49%	#24 of 47
NIFTY MIDSMALLCAP 400 NIFTYMIDSML400	$1.14 Trillion	0.15%	#184 of 400
NIFTY TOTAL MARKET NIFTYTOTALMKT	$3.20 Trillion	0.05%	#271 of 750
NIFTY SMALLCAP 250 NISM250	$385.45 Billion	0.44%	#85 of 250

Weight: Jubilant Pharmova Limited's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.

Jubilant Pharmova Limited Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Jubilant Pharmova Limited's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

0.03x

Jubilant Pharmova Limited's market cap is 0.03 times its annual revenue

Industry average: 0.53x Lower than industry average

Latest Price to Earnings (P/E) Ratio

0.22x

Jubilant Pharmova Limited's market cap is 0.22 times its annual earnings

Industry average: 0.02x Higher than industry average

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
2016	$865.85 Million	$57.49 Billion	$3.92 Billion	0.02x	0.22x
2017	$1.09 Billion	$58.61 Billion	$5.76 Billion	0.02x	0.19x
2018	$989.00 Million	$75.18 Billion	$6.43 Billion	0.01x	0.15x
2019	$757.07 Million	$91.11 Billion	$5.74 Billion	0.01x	0.13x
2020	$1.20 Billion	$59.76 Billion	$8.98 Billion	0.02x	0.13x
2021	$970.90 Million	$60.99 Billion	$8.36 Billion	0.02x	0.12x
2022	$630.31 Million	$61.30 Billion	$4.14 Billion	0.01x	0.15x
2023	$927.51 Million	$62.82 Billion	-$610.00 Million	0.01x	N/A
2024	$1.89 Billion	$67.03 Billion	$771.00 Million	0.03x	2.46x
2025	$1.84 Billion	$72.34 Billion	$8.39 Billion	0.03x	0.22x

Competitor Companies of JUBLPHARMA by Market Capitalization

Companies near Jubilant Pharmova Limited in the global market cap rankings as of June 17, 2026.

Key companies related to Jubilant Pharmova Limited by market ranking:

Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
GALDERMA GROUP AG (NYSE:GALDY): Ranked #561 globally with a market cap of $48.78 Billion USD.
Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #624 globally with a market cap of $44.20 Billion USD ( CN¥302.05 Billion CNY).
Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #635 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#513	Takeda Pharmaceutical Co Ltd ADR	NYSE:TAK	$52.60 Billion	$16.65
#561	GALDERMA GROUP AG	NYSE:GALDY	$48.78 Billion	$43.22
#624	Jiangsu Hengrui Medicine Co Ltd	SHG:600276	$44.20 Billion	CN¥47.35
#635	Takeda Pharmaceutical Company Limited	F:TKDA	$43.60 Billion	€13.60

Jubilant Pharmova Limited Historical Marketcap From 2015 to 2026

Between 2015 and today, Jubilant Pharmova Limited's market cap moved from $564.68 Million to $ 1.68 Billion, with a yearly change of 11.32%.

Year	Market Cap	Change (%)
2026	Rs1.68 Billion	-8.69%
2025	Rs1.84 Billion	-2.89%
2024	Rs1.89 Billion	+104.11%
2023	Rs927.51 Million	+47.15%
2022	Rs630.31 Million	-35.08%
2021	Rs970.90 Million	-19.19%
2020	Rs1.20 Billion	+58.70%
2019	Rs757.07 Million	-23.45%
2018	Rs989.00 Million	-9.52%
2017	Rs1.09 Billion	+26.24%
2016	Rs865.85 Million	+53.33%
2015	Rs564.68 Million	--

End of Day Market Cap According to Different Sources

On Jun 17th, 2026 the market cap of Jubilant Pharmova Limited was reported to be:

Source	Market Cap
Yahoo Finance	$1.68 Billion USD
MoneyControl	$1.68 Billion USD
MarketWatch	$1.68 Billion USD
marketcap.company	$1.68 Billion USD
Reuters	$1.68 Billion USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Jubilant Pharmova Limited

NSE:JUBLPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$1.68 Billion

Rs155.22 Billion INR

Market Cap Rank

#6927 Global

#312 in India

Share Price

Rs980.00

Change (1 day)

-1.14%

52-Week Range

Rs807.65 - Rs1236.30

All Time High

Rs1269.00